FUL FULLER H B CO

Q3 2025 10-Q
Filed: Sep 25, 2025Period ending Aug 30, 2025
Health Care
Adhesives & SealantsSEC EDGAR

FULLER H B CO (FUL) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Sep 25, 2025 for the fiscal period ending Aug 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • No material changes in risk factors since the most recent 10-K filing
  • Carried-forward risks include general economic conditions impacting demand and supply chain disruptions
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$892M

-2.8% YoY -0.7% QoQ

Net Income

$67M

+21.3% YoY +60.6% QoQ

Gross Margin

32.0%

+192bp YoY +7bp QoQ

Operating Margin

12.3%

+98bp YoY +121bp QoQ

Net Margin

7.5%

+150bp YoY +287bp QoQ

ROE

3.4%

Total Assets

$5.2B

EPS (Diluted)

$1.22

+24.5% YoY +62.7% QoQ

Operating Cash Flow

$99M

+12.7% YoY -10.6% QoQ

Source: XBRL data from FULLER H B CO Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on FULLER H B CO

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.